CA2549965A1 - Alcynes iii - Google Patents
Alcynes iii Download PDFInfo
- Publication number
- CA2549965A1 CA2549965A1 CA002549965A CA2549965A CA2549965A1 CA 2549965 A1 CA2549965 A1 CA 2549965A1 CA 002549965 A CA002549965 A CA 002549965A CA 2549965 A CA2549965 A CA 2549965A CA 2549965 A1 CA2549965 A1 CA 2549965A1
- Authority
- CA
- Canada
- Prior art keywords
- prop
- methyl
- hydrogen
- pyridine
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56075403P | 2003-10-31 | 2003-10-31 | |
US60/560,754 | 2003-10-31 | ||
PCT/US2004/034501 WO2005044265A1 (fr) | 2003-10-31 | 2004-10-20 | Alcynes iii |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2549965A1 true CA2549965A1 (fr) | 2005-05-19 |
Family
ID=34573078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002549965A Abandoned CA2549965A1 (fr) | 2003-10-31 | 2004-10-20 | Alcynes iii |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1677788A1 (fr) |
JP (1) | JP2007509934A (fr) |
CN (1) | CN1871001A (fr) |
CA (1) | CA2549965A1 (fr) |
WO (1) | WO2005044265A1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0413605D0 (en) | 2004-06-17 | 2004-07-21 | Addex Pharmaceuticals Sa | Novel compounds |
WO2008031550A2 (fr) | 2006-09-11 | 2008-03-20 | Novartis Ag | Nouvelles utilisations de récepteurs de glutamate métabotropiques |
AR065792A1 (es) * | 2007-03-21 | 2009-07-01 | Speedel Experimenta Ag | Proceso para preparar (r o s) -5- (1 -azido-3-(6-metoxi-5-(3-metoxi-propoxi) -piridin-3-ilmetil) -4-metil- pentil) -3-alquil-dihidro-furan-2-ona |
WO2010000763A2 (fr) | 2008-06-30 | 2010-01-07 | Novartis Ag | Produits de combinaison |
JP2012533601A (ja) | 2009-07-23 | 2012-12-27 | ノバルティス アーゲー | 運動失調症の処置または予防のための、アザビシクロアルキル誘導体またはピロリジン−2−オン誘導体の使用 |
TWI558398B (zh) | 2009-09-22 | 2016-11-21 | 諾華公司 | 菸鹼乙醯膽鹼受體α7活化劑之用途 |
WO2011048150A1 (fr) | 2009-10-20 | 2011-04-28 | Novartis Ag | Utilisation de 1h-quinazoline-2,4-diones |
AU2011268865A1 (en) | 2010-06-24 | 2013-01-31 | Novartis Ag | Use of 1H-quinazoline-2,4-diones |
EA201391091A1 (ru) | 2011-01-27 | 2013-12-30 | Новартис Аг | Применение активаторов никотиновых ацетилхолиновых рецепторов альфа-7 |
IN2014DN01791A (fr) | 2011-09-07 | 2015-05-15 | Novartis Ag | |
ES2865736T3 (es) | 2013-01-15 | 2021-10-15 | Novartis Ag | Uso de agonistas del receptor de acetilcolina nicotínico alfa 7 |
EP2945626B1 (fr) | 2013-01-15 | 2018-09-12 | Novartis AG | Utilisation d'agonistes du récepteur nicotinique alpha 7 pour le traitement de la narcolepsie |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW544448B (en) * | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
AU780009B2 (en) * | 1999-08-31 | 2005-02-24 | Merck Sharp & Dohme Corp. | Heterocyclic compounds and methods of use thereof |
AU2002218200B2 (en) * | 2000-10-03 | 2004-08-05 | Syngenta Participations Ag | Phenylpropynyloxypyridine herbicides |
GB0103045D0 (en) * | 2001-02-07 | 2001-03-21 | Novartis Ag | Organic Compounds |
AR035087A1 (es) * | 2001-08-09 | 2004-04-14 | Syngenta Participations Ag | Piridil-alquinos y piridil-n-oxido-alquinos herbicidas activos, procedimiento para su preparacion, composicion herbicida y para inhibir el crecimiento de plantas, metodo para el control del crecimiento de plantas indeseables , y metodo para la inhibicion del crecimiento de plantas |
US20040116462A1 (en) * | 2002-12-12 | 2004-06-17 | Mitsunori Ono | Indolizine compounds |
-
2004
- 2004-10-20 EP EP04795637A patent/EP1677788A1/fr not_active Withdrawn
- 2004-10-20 CN CNA2004800310799A patent/CN1871001A/zh active Pending
- 2004-10-20 CA CA002549965A patent/CA2549965A1/fr not_active Abandoned
- 2004-10-20 WO PCT/US2004/034501 patent/WO2005044265A1/fr not_active Application Discontinuation
- 2004-10-20 JP JP2006538083A patent/JP2007509934A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1871001A (zh) | 2006-11-29 |
WO2005044265A1 (fr) | 2005-05-19 |
EP1677788A1 (fr) | 2006-07-12 |
JP2007509934A (ja) | 2007-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI453197B (zh) | 可用作抗菌劑之氟吡啶酮衍生物 | |
US10323001B2 (en) | Compositions for modulating a kinase cascade and methods of use thereof | |
JP6021838B2 (ja) | たんぱく質キナーゼインヒビターとして有用なジヒドロピリジン誘導体 | |
JP5564251B2 (ja) | キナーゼカスケードを調節するためのビアリール組成物および方法 | |
US8563583B2 (en) | Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists | |
CA2549965A1 (fr) | Alcynes iii | |
JP2009542680A5 (fr) | ||
JP2007525513A (ja) | 糖尿病の処置に有用なヘテロアリールアミノピラゾール誘導体 | |
EP1677789A1 (fr) | Alkynes i | |
EP1028110A1 (fr) | Nouveaux composes a base de dihydronaphtalene et leur procede de production | |
EP1677790A1 (fr) | Alkynes ii | |
US7495001B2 (en) | Benzannelated derivatives, their manufacture and use as pharmaceutical agents | |
KR20070097574A (ko) | Ppar 활성화제로서의 아미드 유도체 | |
Chicca et al. | Biological evaluation of pyridone alkaloids on the endocannabinoid system | |
JP2004517870A (ja) | シクロオキシゲナーゼ阻害剤 | |
US20210198202A1 (en) | Compositions for modulating a kinase cascade and methods of use thereof | |
US7179812B2 (en) | Diazine derivatives | |
TWI828783B (zh) | 聯芳基衍生物及其用途 | |
JP2009196985A (ja) | 医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |